Total Liabilities Summary of Sino Biopharmaceutical Limited

Sino Biopharmaceutical Limited's latest annual total liabilities in 2023 was 25.43 Billion CNY , down -2.63% from previous year.
Sino Biopharmaceutical Limited's latest quarterly total liabilities in 2024 Q2 was 24.58 Billion CNY , down 0.0% from previous quarter.
Sino Biopharmaceutical Limited reported annual total liabilities of 26.12 Billion CNY in 2022, up 14.49% from previous year.
Sino Biopharmaceutical Limited reported annual total liabilities of 22.81 Billion CNY in 2021, down -7.97% from previous year.
Sino Biopharmaceutical Limited reported quarterly total liabilities of 24.58 Billion CNY for 2024 Q1, down -3.35% from previous quarter.
Sino Biopharmaceutical Limited reported quarterly total liabilities of 25.43 Billion CNY for 2023 Q4, down 0.0% from previous quarter.

Annual Total Liabilities Chart of Sino Biopharmaceutical Limited (2023 - 1999)

Historical Annual Total Liabilities of Sino Biopharmaceutical Limited (2023 - 1999)

Year	Total Liabilities	Total Liabilities Growth
2023	25.43 Billion CNY	-2.63%
2022	26.12 Billion CNY	14.49%
2021	22.81 Billion CNY	-7.97%
2020	24.79 Billion CNY	37.61%
2019	18.01 Billion CNY	47.29%
2018	12.23 Billion CNY	46.93%
2017	8.32 Billion CNY	8.08%
2016	7.7 Billion CNY	52.29%
2015	5.05 Billion CNY	18.31%
2014	4.27 Billion CNY	99.36%
2013	2.14 Billion CNY	31.15%
2012	1.63 Billion CNY	32.98%
2011	1.22 Billion CNY	9.35%
2010	1.12 Billion CNY	72.95%
2009	650.1 Million CNY	19.97%
2008	541.9 Million CNY	54.11%
2007	351.63 Million CNY	91.0%
2006	184.1 Million CNY	7.21%
2005	171.73 Million CNY	-34.93%
2004	263.92 Million CNY	3.28%
2003	255.54 Million CNY	40.44%
2002	181.95 Million CNY	86.77%
2001	97.42 Million CNY	-36.31%
2000	152.96 Million CNY	8.34%
1999	141.18 Million CNY	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q2	24.58 Billion CNY	0.0%
2024 Q1	24.58 Billion CNY	-3.35%
2023 Q4	25.43 Billion CNY	0.0%
2023 FY	25.43 Billion CNY	-2.63%
2023 Q3	25.43 Billion CNY	-12.84%
2023 Q2	29.18 Billion CNY	0.0%
2023 Q1	29.18 Billion CNY	11.72%
2022 Q2	26.18 Billion CNY	0.0%
2022 Q4	26.12 Billion CNY	0.0%
2022 FY	26.12 Billion CNY	14.49%
2022 Q3	26.12 Billion CNY	-0.26%
2022 Q1	26.18 Billion CNY	14.8%
2021 FY	22.81 Billion CNY	-7.97%
2021 Q1	24.3 Billion CNY	-1.98%
2021 Q2	25.09 Billion CNY	3.28%
2021 Q3	22.81 Billion CNY	-9.1%
2021 Q4	22.81 Billion CNY	0.0%
2020 Q1	25.55 Billion CNY	41.87%
2020 Q2	26.84 Billion CNY	5.04%
2020 Q3	25.74 Billion CNY	-4.12%
2020 Q4	24.79 Billion CNY	-3.69%
2020 FY	24.79 Billion CNY	37.61%
2019 Q2	14.65 Billion CNY	8.79%
2019 Q1	13.47 Billion CNY	10.18%
2019 Q4	18.01 Billion CNY	23.05%
2019 FY	18.01 Billion CNY	47.29%
2019 Q3	14.63 Billion CNY	-0.14%
2018 FY	12.23 Billion CNY	46.93%
2018 Q2	10.68 Billion CNY	7.83%
2018 Q1	9.91 Billion CNY	19.08%
2018 Q4	12.23 Billion CNY	2.91%
2018 Q3	11.88 Billion CNY	11.19%
2017 Q3	8.68 Billion CNY	-0.05%
2017 Q4	8.32 Billion CNY	-4.21%
2017 Q2	8.69 Billion CNY	-0.34%
2017 Q1	8.72 Billion CNY	13.28%
2017 FY	8.32 Billion CNY	8.08%
2016 FY	7.7 Billion CNY	52.29%
2016 Q3	7.85 Billion CNY	19.67%
2016 Q4	7.7 Billion CNY	-1.91%
2016 Q1	5.98 Billion CNY	18.26%
2016 Q2	6.56 Billion CNY	9.7%
2015 FY	5.05 Billion CNY	18.31%
2015 Q4	5.05 Billion CNY	-18.53%
2015 Q2	6 Billion CNY	20.6%
2015 Q1	4.98 Billion CNY	16.54%
2015 Q3	6.2 Billion CNY	3.32%
2014 Q4	4.27 Billion CNY	-0.57%
2014 Q2	4.5 Billion CNY	55.4%
2014 Q3	4.29 Billion CNY	-4.49%
2014 FY	4.27 Billion CNY	99.36%
2014 Q1	2.89 Billion CNY	35.1%
2013 Q4	2.14 Billion CNY	-11.77%
2013 FY	2.14 Billion CNY	31.15%
2013 Q3	2.43 Billion CNY	2.3%
2013 Q2	2.37 Billion CNY	19.71%
2013 Q1	1.98 Billion CNY	21.37%
2012 Q3	2.07 Billion CNY	10.89%
2012 Q4	1.63 Billion CNY	-21.31%
2012 FY	1.63 Billion CNY	32.98%
2012 Q2	1.87 Billion CNY	0.0%
2011 Q4	1.22 Billion CNY	-26.45%
2011 Q1	1.23 Billion CNY	0.0%
2011 FY	1.22 Billion CNY	9.35%
2011 Q2	1.75 Billion CNY	41.49%
2011 Q3	1.67 Billion CNY	-4.6%
2010 Q2	1 Billion CNY	0.0%
2010 FY	1.12 Billion CNY	72.95%
2009 Q4	650.1 Million CNY	0.0%
2009 FY	650.1 Million CNY	19.97%
2008 FY	541.9 Million CNY	54.11%
2007 FY	351.63 Million CNY	91.0%
2006 FY	184.1 Million CNY	7.21%
2005 FY	171.73 Million CNY	-34.93%
2004 FY	263.92 Million CNY	3.28%
2003 FY	255.54 Million CNY	40.44%
2002 FY	181.95 Million CNY	86.77%
2001 FY	97.42 Million CNY	-36.31%
2000 FY	152.96 Million CNY	8.34%
1999 FY	141.18 Million CNY	0.0%

Peer Total Liabilities Comparison of Sino Biopharmaceutical Limited

Name	Total Liabilities	Total Liabilities Difference
Uni-Bio Science Group Limited	152.81 Million HKD	-16543.894%
CK Life Sciences Int'l., (Holdings) Inc.	7.05 Billion HKD	-260.361%

Global Stocks Search

Sino Biopharmaceutical Limited (1177.HK)

Total Liabilities Summary of Sino Biopharmaceutical Limited

Annual Total Liabilities Chart of Sino Biopharmaceutical Limited (2023 - 1999)

Historical Annual Total Liabilities of Sino Biopharmaceutical Limited (2023 - 1999)

Peer Total Liabilities Comparison of Sino Biopharmaceutical Limited